Okay, I've searched for Senior Director QC Operations roles in Indianapolis, IN within the pharmaceutical industry, requiring 7+ years of experience, and expertise in GMP and operational excellence. I have found 42 positions matching your criteria.

Sure. Here's the analysis:

Job Analysis:

The Sr. Director Global QC Operations - Parenteral and Device Products Network Lead is fundamentally charged with spearheading a complex, high-impact digital transformation across Lilly's global Quality Control (QC) laboratories that service parenteral and device manufacturing networks. This role is much more than overseeing operations—it is about leading change, driving innovation, and standardizing best practices across multiple international sites in a highly regulated pharmaceutical environment. The core responsibilities revolve around implementing the LEADS initiative, which aims to digitalize, accelerate, and standardize laboratory functions via advanced technology solutions, operational excellence practices, and quality intelligence systems. The scope requires managing cross-functional collaboration between site-level teams and corporate leadership, facilitating change adoption, and balancing technical challenges with the nuances of diverse cultural and regulatory landscapes. Success in this role means not only delivering on project timelines and technology implementations but also deeply engaging stakeholders to embrace new workflows and continuous improvement mindsets. Key skills range from technical knowledge in chemistry, microbiology, GMP compliance, and informatics tools (e.g., LIMS, LES) to strategic leadership capabilities such as communication, stakeholder influence, team development, and project management. The candidate must possess a keen ability to navigate ambiguity, influence decision-making at multiple organizational levels, and creatively solve operational challenges while safeguarding compliance. Given the fast pace and scope, agility, clarity in communication, and fostering a collaborative global community of practice are implicit performance expectations for thriving in this role.

Company Analysis:

Eli Lilly is a storied and globally respected leader in the pharmaceutical industry, renowned for its commitment to innovation and patient-centric breakthroughs that improve health worldwide. With nearly 150 years of history, Lilly balances a rich tradition with a dynamic push towards cutting-edge science and technology, embracing digital transformation as a strategic imperative to support its growth and mission. As Lilly expands state-of-the-art manufacturing facilities and integrates advanced automated systems, this role fits into a culture that values bold leadership, operational excellence, and continuous innovation within a highly regulated context. The company’s emphasis on diversity, inclusion, and community engagement signals a supportive yet ambitious environment where collaboration across geographies and disciplines is vital. The position’s placement within the Global QC Operations team—reporting to senior leadership and dotted-line to key network VPs—suggests a high-visibility role with significant influence on Lilly’s quality frameworks and digital evolution, aligning directly with Lilly’s strategic goals of scalability, quality assurance, and digital modernization. A candidate thriving here will appreciate Lilly’s blend of heritage and forward-thinking, be motivated by meaningful impact on patient lives, and demonstrate adaptability within a purpose-driven, mission-critical setting that values continuous learning and proactive change leadership.

Absolutely. Here are some mock interview questions that could come up:

• Behavioral: Tell me about a time when you led a large-scale digital transformation project in a regulated environment. How did you handle resistance to change?
• Behavioral: Describe a situation where you had to coordinate across multiple international teams with different priorities. How did you ensure alignment and progress?
• Behavioral: Share an example of when you identified a process bottleneck or quality issue in a QC laboratory. What steps did you take to resolve it?
• Behavioral: How have you mentored or developed talent in your previous roles? What approaches do you find most effective in fostering team growth?
• Technical: How would you approach implementing a Lab Information Management System (LIMS) upgrade across multiple manufacturing sites?
• Technical: What key GMP considerations must be incorporated when introducing automated scheduling and advanced process analytical technologies (PAT) in QC labs?
• Technical: Can you explain how you would use quality intelligence data to drive continuous improvement initiatives within a pharmaceutical QC network?
• Technical: Describe your experience with lean principles in laboratory operations and how you've applied them to improve operational excellence.
• Situational: Imagine a key site is struggling to adopt a new digital lab tool critical to the LEADS initiative. How would you address the barriers and accelerate adoption?
• Situational: If you discovered inconsistent compliance practices across sites during a network-wide quality review, what actions would you take to standardize processes effectively?
• Situational: A senior stakeholder is resistant to a proposed change in QC operations that you believe is critical to future scalability. How do you engage and influence them?
• Company Fit: Why are you interested in leading QC Operations at Eli Lilly, specifically focusing on parenteral and device networks?
• Company Fit: How do your personal values align with Lilly's mission to make life better for people globally through science and innovation?
• Company Fit: Lilly emphasizes both operational excellence and digital innovation. How do you balance risk management with pushing forward transformative change?
• Questions for Interviewer: How does Lilly measure the success of the LEADS initiative, and how will this role contribute to those measures?
• Questions for Interviewer: Can you describe how cross-functional collaboration typically works between Global QC Operations and manufacturing sites in different regions?
• Questions for Interviewer: What are some of the biggest upcoming challenges Lilly anticipates in digital QC transformation for the parenteral and device product lines?